INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $58,496,942 | -17.1% | 1,569,545 | -22.4% | 0.28% | -22.1% |
| Q4 2022 | $70,526,995 | -33.3% | 2,021,410 | +7.0% | 0.35% | -27.7% |
| Q3 2022 | $105,712,000 | -8.3% | 1,889,067 | -15.2% | 0.49% | -7.6% |
| Q2 2022 | $115,341,000 | -35.7% | 2,228,383 | -9.7% | 0.53% | -27.2% |
| Q1 2022 | $179,405,000 | -3.9% | 2,468,760 | +56.3% | 0.72% | +34.8% |
| Q4 2021 | $186,764,000 | +8.8% | 1,579,536 | +23.4% | 0.54% | +14.2% |
| Q3 2021 | $171,649,000 | +8.7% | 1,279,531 | +31.2% | 0.47% | -1.7% |
| Q2 2021 | $157,877,000 | – | 975,092 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |